Constraints to organs at risk for treatment of head and neck cancers by intensity modulated radiation therapy;Les contraintes aux organes à risque en radiothérapie par modulation d'intensité des cancers ORL

Cancer/Radiotherapie

Volumn 8, Issue 4, 2004, Pages 234-247

  Maingon, P ^a   Mammar, V ^a   Peignaux, K ^a   Truc, G ^a   Barillot, I ^a  

^a CENTRE GEORGES FRANÇOIS LECLERC   (France)

Author keywords

Cancer de la sph re ORL; Head and neck neoplasms; Intensity modulated radiation therapy; Organes risque; Organs at risk; Radioth rapie par modulation d'intensit

Indexed keywords

CORRELATION ANALYSIS; FRACTIONATION; GAMMA RADIATION; HEAD AND NECK CANCER; HISTOGRAM; HUMAN; OPTIC CHIASM; ORGAN INJURY; PAROTID GLAND; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE; RADIATION HAZARD; RADIATION RESPONSE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SALIVARY GLAND; TEMPOROMANDIBULAR JOINT;

EID: 4644262319     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2004.06.002     Document Type: Short Survey

References (60)

1. Abatucci J.S., Delozier T., Quint R., Roussel A., Brune D. Radiation myelopathy of the cervical spinal cord : time, dose and volume factors. Int J Radiat Oncol Biol Phys. (3-4):1978;239-248
2. Atkins H.L., Tretter P. Time dose considerations in radiation myelopathy. Acta Radiol. 5:1966;79-94
3. Bedwineck J. III, Shulovsky I.J., Fletcher G.H., Daly T.E. Osteonecrosis in patients treated with definitive radiotherapy for squamous cell carcinoma of the oral cavity and nasopharynx. Radiology. 119:1976;665
4. Bessel E., Henk J.M., Whitelocke R.A.F., Wright J.E. Ocular morbidity after radiotherapy of orbital and conjonctival lymphoma. Eye. 1:1987;90-96
5. Beumer J. III, Curtis T.A., Morrish R.B. Jr. Radiation complication in edentelous patients. J Prothest Dent. 36:1976;193
6. Burman C., Kutcher G.J., Emami B., Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 21:1991;123-135
7. Chan R., Shukovsky L.J. Effects of irradiation on the eye. Radiology. 120:1982;144-151
8. Chao K.S., Deasy J.O., Markman J., Haynie J., Perez C.A., Purdy J.A. A prospective study of salivary function sparing in patients with head and neck cancers receiving intentinsity-modulated or three dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys. 49:(4):2001;907-916
9. Chao K.S., Majhail N., Huang C.H., Simpson J.R., Perez C.A., Haughey B., et al. Intensity-modulated radiotherapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparaison with conventional techniques. Radiother Oncol. 61:(3):2001;275-280
10. Chavaudra J., Bridier A. Définition des volumes en radiothérapie externe : rapports ICRU 50 et 62. Cancer radiother. 5:(5):2001;472-478
11. Choi K.N., Rotman M., Aziz H., Potters L., Stark R., Rosenthal J.C., et al. Locally advanced paranasal sinus and nasopharynx tumors treated with hyperfractionated radiation and concomitant infusion cisplatin. Cancer. 67:1991;2748-2752
12. Claus F., de Gersen W., de Wagter C., Van Severen R., Van Houtte I., De Neve W., et al. An implementation strategy for IMRT of ethmoïd sinus cancer with bilateral sparing of the optic pathway. Int. J. Radiat. Oncol.Biol.Phys. 51:(2):2001;318-331
13. Cozzi L., Fogliata A., Lomax A., Bolsi A. A treatment planning comparaison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumors. Radiother Oncol. 61:(3):2001;287-297
14. Dale E., Obsen D.R. Specification of the dose to organs at risk in external beam therapy. Acta Oncol. 36:(2):1997;129-135
15. De Crevoisier R., Bourhis J., Domenge C., Wibault P., Koscielny S., Eschwège F., et al. Full-dose reirradiation for unresecable head and neck carcinoma : experience at the Gustave-Roussy Institute in a serie of 169 patients. J Clin Oncol. 16:(11):1998;3556-3562
16. Deeg H.J., Flournoy N., Sullivan K.M., Sheehan K., Buckner CD., Sanders JE., et al. Cataracts after total body irradiation and marrow transplantation. A sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys. 10:1984;957-964
17. Dische S., Saunders M.I. Continuous, Hyperfractionated, accelerated, fractionation (CHART): a interim report upon late morbidity. Radiother Oncol. 16:1989;67-74
18. Eisbruch A., Dawson L.A., Kim H.M., Bradford C.R., Terrel J.E., et al. conformal and intensity modulated irradiation in head and neck cancer: the potential for improved target irradiation, salivary gland fonction, and quality of life. Acta Otorhinolaryngol Belg. 53:(3):1999;271-275
19. Eisbruch A., Kim H.M., Terrell J.E., Marsh L.H., Dawson L.A., Ship J.A. Xerostomia and its predictors following parotid-sparing irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 50:(3):2001;695-704
20. Eisbruch A., Ten Haken R.K., Kim H.M., Marsh L.H., Ship J.A. Dose, Volume, and function relationships in parotid salivary glands following conformal and intensity modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 45:(3):1999;577-587
21. Emami B., Lyman J., Brown A., Coia L., Goiten M., Munzen-rider J.E., Shank B., Solin L.J., Wesson M. Tolerance of normal tissue to therapeutic radiation. Int J Radiat Oncol Biol Phys. 21:1991;109-122
22. Evans A., Bleyer A.W., Kaplan R., et al. Central Nervous system worshop. Cancer clin Trials. 4:(suppl):1981;31-35
23. Fletcher G.H., Shukovsky L.J. Retinal and optic nerve complications in a high dose irradiation technique of ethmoid sinus and nasal cavity. Radiology. 104:1972;629-634
24. Franzen L., Funegard U., Ericson T., Henriksson R. Parotid gland function during and following radiotherapy of malignancies in the head and neck. Eur J Cancer. 28:(2-3):1992;457-462
25. Goldsmith B.J., Rosenthal S.A., Wara W.M., Larson D.A. Optic Neuropathy after irradiation of meningioma. Radiology. 185:1992;71-76
26. Hammer H.M. Optic chiasmal radionecrosis. Trans. Ophtalmol. Soc UK. 103:1983;208-211
27. Henk J.M., Whitelocke R.A.F., Warrington A.P., Bessel M. Radiation dose to the lens and cataract formation. Int J Radiat Oncol Biol Phys. 25:1993;815-820
28. Heyn R., Ragab A., Raney R.B., Ruymann F., Tefft M., Lawrence W., Soule E., Maurer H.M. Late effects of therapy in orbital rhabdomyosarcoma in children. A report from intergroup Rhabdomyosarcoma study. Cancer. 57:1986;1738-1743
29. Horiot J.C., Bontemps P., van den Bogaert W., Le Fur R., van den Weijngaert D., Bolla M., Bernier J., Lusinchi A., et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol. 44:1997;111-121
30. Horiot J.C., Chaplain G., Van der Schueren E., Gonzales Gonzales, Van den Bogaert W., van Limbergen E., et al. EORTC Cooperative Group of Radiotherapy Protocol 22851. A phase III study of accelerated fractionation in the radiotherapy of advanced head and neck carcinoma. 1985;EORTC data Center Brussels
31. ICRU. Prescribing, Recording, and Reporting Photon Beam Therapy (supplement to ICRU 50). ICRU Report 62. 1999;International Commission on radiation Units and Measurements, Bethesda, MD
32. ICRU. Prescribing, Recording, and Reporting Photon Beam Therapy. ICRU report 50. 1993;International Commission on Radiation Units and Measurements, Bethesda, MD
33. Jiang G.L., Tucker S.L., Guttenberger R., Peters L.J., Morrison W.H., Garden A.S., et al. Radiation induced injury to the visual pathway. Radiother.Oncol. 30:1994;17-25
34. Kulik C., Mazurier J., Lartigau E. Probabilité de contrôle tumoral et de complications (TCP/NTCP) après radiothérapie. : aspects méthodologiques, physiques et biologiques. Cancer Radiother. 6:(1):2002;155s-165s
35. Kutcher G.J., Burman C., Brewster L., Goeiten M., Mohan R. Histogram reduction method for calculating complication probabilities for 3D planning evaluations. Int J Radiat Oncol Biol Phys. 21:1991;137-146
36. Kutcher G.J., Burman C. Calculation of complication probability factors for non uniform normal tissue irradiation : the effective volume method. Int J Radiat Oncol Biol Phys. 16:(6):1989;1623-1630
37. Leslie M.D., Dische S. The early changes in salivary gland function during and after radiotherapy given for head and neck cancer. Radiother Oncol. 30:(1):1994;26-32
38. Letschert J.G., Gonzales D., Oskam J., Koornneef L., Van Dijk J.D.P. Results of radiotherapy in patients with stage I orbital lymphoma. Radiother.Oncol. 22:1991;36-44
39. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat.Res. 104:1985;S13-S19
40. Lyman J.T., Wolbarst A.B. Optimisation of radiation therapy: A method of assessing complication probabilities from dose-volume histograms. Int J Radiat Oncol Biol Phys. 13:1987;101-109
41. Lyman J.T. Normal Tissue Complications Probability: variable dose per fraction. Int J Radiat Oncol Biol Phys. 22:1992;247-250
42. Manning M.A., Wu Q., Cardinale R.M., Mohan R., Lauve A.D., Kavanagh B.D. The effect of set up uncertainty on normal tissue sparing with IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys. 51:2001;1400-1409
43. Marcus R.B., Million R.R. The incidence of myelitis after irradiation of the cervical spinal cord. Int J Radiat Oncol Biol Phys. 19:1990;3-5
44. Martel M.K., Sandler H.M., Cornblath W.T., Marsh L.H., Hazuka M.B., Roa W.H., et al. Dose volume complication analysis for visual patway structures of patients with advanced paranasal sinus tumors. Int J Radiat Oncol Biol Phys. 38:(2):1997;273-284
45. McCunniff A.J., Liang M.J. Radiation tolerance of the cervical spinal cord. Int J Radiat Oncol Biol Phys. 16:(3):1989;675-678
46. McKenzie A., Van Herk M., Mijnheer B. Margins for geometric uncertainty around organs at risk in radiotherapy. Radiother Oncol. 62:2002;299-307
47. Meecham W.J., Char D.H., Kroll S., Castro J.R., Blakely E.A. Anterior segment complications after helium ion radiation therapy for uveal melanoma radiation cataract. Arch. Ophtalmol. 112:(2):1994;197-203
48. Morrish R.B., Chan E., Silverman S. Jr, Meyer J., Fu K.K., Greenpan D. Osteoradionecrosis in patients irradiated for head and neck carcinoma. Cancer. 47:1981;1980
49. Muren L.P., Jebsen N., Gustafsson A., Dahl O. Dose response models predict reliable NTCP. Int J Radiat Oncol Biol Phys. 50:2001;627-637
50. Murray C.G., Herson J., Daly T.E., Zimmerman S. Radiation necrosis of the mandible. A 10 year study. Part I. Factors influencing the onset of necrosis. Int J Radiat Oncol Biol Phys. 6:1980;543
51. Nakissa N., Rubin P., Strhol R., Keys H. Ocular and orbital complications following radiation therapy of parasinusal malignancies. Cancer. 51:1983;980-986
52. Niemerko A. Reporting and analysing dose distribution: a concept of equivalent uniform dose. Med Phys. 24:1997;103-110
53. Notis C., Abramson D., Sagerman R.H., Ellsworth R.M. Orbital Rhabdomyosarcoma: Treatment or overtreatment. Ophtalmology. 100:(suppl. 9A):1993;79
54. Oberlin O, Rey A, Anderson J, Carli M, Raney RB, Treuner J, Stevens MC; International Society of Paediatric Oncology Sarcoma Committee, Intergroup Rhabdomyosarcoma Study Group, Italian Cooperative Soft Tissue Sarcoma Group, German Collaborative Soft Tissue Sarcoma Group. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment - results of an international workshop. J Clin Oncol. 19:(1):2001;197-204
55. Parsons J.T., Bova F.J., Fitzgerald C.R., Mendenhall W.D., Million R.R. Radiation retinopathy after megavoltage external-beam irradiation: analysis of time dose factors. Int J Radiat Oncol Biol Phys. 30:(4):1994;765-773
56. Peterson I.A., Kriss J.P., McDougall I.R., Donaldson S.S. Prognostic factors of Graves ophtalmopathy. Int J Radiat Oncol Biol Phys. 19:1990;259-264
57. Roesink J.M., Moerland M.A., Battermann J.J., Hordijk G.J., Terhaard C.H. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head and neck region. Int J Radiat Oncol Biol Phys. 51:(4):2001;938-946
58. Sultanem K., Shu H.K., Xia P., Akasawa C., Quivey J.M., Verrhey L.J., et al. Three-dimensional intensity-modulated radiothérapy in the treatment of nasopharyngeal carcinoma: The University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 48:2000;711-722
59. Wu Q., Manning M., Schmidt-Ullrich R., Mohan R. The potential for tissue sparing and escalation of biologically effective dose with IMRT of head and neck cancer: a treatment design study. Int J Radiat Oncol Biol Phys. 46:2000;195-205
60. Wu Q., Mohan R., Niemerko A. Rupert Schmidt-Ullrich. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys. 52:(1):2002;224-235